Table 3:

Longitudinal analysis controlling for T2LV and WBVa

RegionModel 1Model 2Change
R2PPbR2PPbΔR2PPb
Left thalamus0.156.000.0000.160.000.0000.004.181.984
Right thalamus0.141.000.0000.147.000.0000.006.137.984
Left caudate0.067.007.0280.074.005.0200.007.135.984
Right caudate0.084.002.0140.092.001.0080.008.123.984
Left putamen0.146.000.0000.164.000.0000.018.034.340
Right putamen0.055.016.0360.130.000.0000.075.000.000
Left globus pallidus0.140.000.0000.164.000.0000.024.017.187
Right globus pallidus0.152.000.0000.161.000.0000.009.101.909
Left hippocampus0.102.000.0000.097.001.008−0.005.7291.00
Right hippocampus0.098.0001.0000.094.001.0080.004.5901.00
Left amygdala0.059.012.0360.062.012.0240.003.207.984
Right amygdala−0.013.711.7110.028.106.1060.041.005.065
Left accumbens0.070.005.0250.104.008.0240.034.008.096
Right accumbens0.084.002.0140.086.002.0100.002.240.984
  • Note:—ΔWBV indicates change in whole-brain volume; ΔT2LV, change in T2 lesion volume.

  • a Hierarchic regression analyses predicting regional SGM 5-year atrophy. Predictors included in each model are as follows: model 1, age, sex, disease duration, ΔWBV, ΔT2LV, baseline tract disruption; model 2, age, sex, disease duration, ΔWBV, ΔT2LV, baseline tract disruption, longitudinal change in disruption of connected WM tracts.

  • b Holm-Bonferroni–corrected P values. All P values are significant.